跳至主要内容
临床试验/IRCT2017021632603N1
IRCT2017021632603N1已完成2 期

Comparison of the effectiveness of levetiracetam and placebo in improving migraine frequency and duration in children aged 4-17 years old.

Vice chancellor for research, Tehran university of medical sciense0 个研究点目标入组 68 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
4 years 至 17 years(—)
性别
All

入选标准

  • Children aged 4-17 years
  • met the diagnostic criteria for pediatric migraine (with or without aura) as defined by the International Headache Society
  • having at least 4 migraineous episodes per month or have severe disabling or intolerable headache

排除标准

  • History of cluster headache, hemiplegic migraine, or chronic daily headaches
  • Headaches related to structural brain lesions
  • Presence of focal neurologic deficit
  • No therapeutic response with at least 3 adequate trials of medication for headache prophylaxis
  • History of levetiracetam sensitivity
  • Other neurological conditions (e.g. epilepsy)

研究者

发起方
Vice chancellor for research, Tehran university of medical sciense

相似试验